Physician profile
Pell Ann Wardrop
NPI 1881689693
$2,081.44
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Sleep Medicine (Otolaryngology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.46 · 2020: $58.99 · 2021: $189 · 2022: $425 · 2023: $773 · 2024: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.52 |
| Education | $128.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $868.15 | 2019-2024 | |
| Harmony Biosciences LLC | $505.38 | 2020-2024 | Wakix |
| Axsome Therapeutics, INC. | $196.39 | 2023-2024 | Sunosi |
| Idorsia Pharmaceuticals US INC | $154.64 | 2023 | Quviviq |
| Azurity Pharmaceuticals, INC. | $107.97 | 2023-2024 | Horizant, Horizant |
| Arbor Pharmaceuticals, INC. | $98.53 | 2019-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $59.84 | 2024 | Lumryz |
| 3b Medical, INC. | $35.59 | 2024 | Luna |
| Inspire Medical Systems, INC. | $19.16 | 2023 | Inspire |
| Resmed Corp | $18.95 | 2023 | |
| Fisher & Paykel Healthcare INC | $16.84 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pell Wardrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.